Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Day

Showing results (251-260 of 501) with videos related to

Pageof 51
Sort By:
Therapeutic Advances in Psychopharmacology|April 9, 2019
Restarting antidepressant and antipsychotic medication after intentional overdoses: need for evidence-based guidanceEmma Tay, Andreas Sotiriou, Garry G Graham, et al.
Therapeutic Drug Monitoring|February 7, 2024
Crying Over Stark Differences: Resource Disparity and Therapeutic Drug MonitoringJane E Carland, Jana Stojanova, Cindy Lau, et al.
Clinical Pharmacology and Therapeutics|May 15, 2026
Ten-Year Public Expenditure Savings Associated with TNF Inhibitor Biosimilars under Australia's Pharmaceutical Benefits SchemeChin Hang Yiu, Bella D Ianni, Richard O Day, et al.
Inorganic Chemistry|October 24, 2001
Conformational Preference and Donor Atom Interaction Leading to Hexacoordination vs Pentacoordination in Bicyclic Tetraoxyphosphoranes(1)David J. Sherlock, A. Chandrasekaran, T. K. Prakasha, et al.
Annals of Emergency Medicine|March 26, 2011
Extreme γ-butyrolactone overdose with severe metabolic acidosis requiring hemodialysisDarren M Roberts, Myles W H Smith, Manivannan Gopalakrishnan, et al.
Internal Medicine Journal|March 8, 2022
Sodium-glucose co-transporter 2 inhibitor therapy: use in chronic kidney disease and adjunctive sodium restrictionMansi Tiwary, Tamara Y Milder, Sophie L Stocker, et al.
Agents and Actions. Supplements|January 1, 1993
Comparative effects of gold on the interactions of transcription factors with DNAM L Handel, S Sivertsen, C K Watts, et al.
Molecular Pharmacology|September 1, 1996
D-penicillamine causes free radical-dependent inactivation of activator protein-1 DNA bindingM L Handel, C K Watts, S Sivertsen, et al.
BMC Health Services Research|August 11, 2012
Nation-scale adoption of new medicines by doctors: an application of the Bass diffusion modelAdam G Dunn, Jeffrey Braithwaite, Blanca Gallego, et al.
British Journal of Clinical Pharmacology|February 1, 1997
1-Methylxanthine derived from caffeine as a pharmacodynamic probe of oxypurinol effectD J Birkett, J O Miners, L Valente, et al.
Pageof 51

Showing results (251-260 of 501) with videos related to

Sort By:
Pageof 51
Therapeutic Advances in Psychopharmacology|April 9, 2019
Restarting antidepressant and antipsychotic medication after intentional overdoses: need for evidence-based guidanceEmma Tay, Andreas Sotiriou, Garry G Graham, et al.
Therapeutic Drug Monitoring|February 7, 2024
Crying Over Stark Differences: Resource Disparity and Therapeutic Drug MonitoringJane E Carland, Jana Stojanova, Cindy Lau, et al.
Clinical Pharmacology and Therapeutics|May 15, 2026
Ten-Year Public Expenditure Savings Associated with TNF Inhibitor Biosimilars under Australia's Pharmaceutical Benefits SchemeChin Hang Yiu, Bella D Ianni, Richard O Day, et al.
Inorganic Chemistry|October 24, 2001
Conformational Preference and Donor Atom Interaction Leading to Hexacoordination vs Pentacoordination in Bicyclic Tetraoxyphosphoranes(1)David J. Sherlock, A. Chandrasekaran, T. K. Prakasha, et al.
Annals of Emergency Medicine|March 26, 2011
Extreme γ-butyrolactone overdose with severe metabolic acidosis requiring hemodialysisDarren M Roberts, Myles W H Smith, Manivannan Gopalakrishnan, et al.
Internal Medicine Journal|March 8, 2022
Sodium-glucose co-transporter 2 inhibitor therapy: use in chronic kidney disease and adjunctive sodium restrictionMansi Tiwary, Tamara Y Milder, Sophie L Stocker, et al.
Agents and Actions. Supplements|January 1, 1993
Comparative effects of gold on the interactions of transcription factors with DNAM L Handel, S Sivertsen, C K Watts, et al.
Molecular Pharmacology|September 1, 1996
D-penicillamine causes free radical-dependent inactivation of activator protein-1 DNA bindingM L Handel, C K Watts, S Sivertsen, et al.
BMC Health Services Research|August 11, 2012
Nation-scale adoption of new medicines by doctors: an application of the Bass diffusion modelAdam G Dunn, Jeffrey Braithwaite, Blanca Gallego, et al.
British Journal of Clinical Pharmacology|February 1, 1997
1-Methylxanthine derived from caffeine as a pharmacodynamic probe of oxypurinol effectD J Birkett, J O Miners, L Valente, et al.
Pageof 51